Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord mesenchymal stromal cells injection
- Development stage
- Unknown
- Lead developer
- BOE Technology Group
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human umbilical cord mesenchymal stromal cells (hUC-MSCs) injection is an allogeneic cell therapy being developed by BOE Technology Group for the treatment of acute ischemic stroke (AIS). hUC-MSCs are multipotent progenitor cells derived from the umbilical cord matrix that possess significant immunomodulatory, anti-inflammatory, and pro-regenerative properties. Upon administration, these cells are thought to migrate to the site of injury and release a variety of paracrine factors, including neurotrophic factors (like BDNF) and angiogenic factors (like VEGF), which help to reduce neuroinflammation, promote tissue repair, and enhance functional recovery. The therapy is currently being evaluated in Phase I clinical trials to assess its safety, tolerability, and preliminary efficacy in patients following an ischemic stroke event.
- Other names
- Human Umbilical Cord Mesenchymal Stem Cells InjectionhUC-MSCshuman umbilical cord-derived mesenchymal stromal cell injection
Beyond the preview
Go deeper on human umbilical cord mesenchymal stromal cells injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord mesenchymal stromal cells injection.